Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Why No TEAC

Why No TEAC

posted on Jan 09, 2008 01:45PM

Per 10Q re revenue recognition:

"Revenue from technology license agreements is recognized at the time we enter into a contract and provide the customer with the licensed technology. At this point, we have performed all of our obligations under contract, the rights to our technology have been transferred and no significant performance obligations remain."

TEAC PR was issued 11/15/07, well before the quarter ended. Why aren't they included in the quarter.

Mr. Turley, inquiring minds want to know!

Share
New Message
Please login to post a reply